Roadmaps to Assess the Environmental Effects of Pharmaceuticals and Their Degradation Products Version 1
SEEK ID: https://fairdomhub.org/data_files/10127?version=1
Filename:
Roadmaps to Assess the Environmental Effects of Pharmaceuticals and Their Degradation Products.docx
Format: Word document
Size: 38.5 KB
Export PNG
Creators and Submitter
Views: 15 Downloads: 3
Created: 29th Oct 2026 at 09:48
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 1 (earliest) Created 29th Oct 2026 at 09:48 by Ulrike Wittig
No revision comments
Related items
Projects: NMTrypI - New Medicines for Trypanosomatidic Infections, Mass spectrometry proteomics for biomarker discovery, Thymidylate synthase dimer dissociation, BioTarget Database, Compound Data, Giulia Malpezzi PhD raw data, Defining the role of fibroblasts in skin expansion, Thymidylate synthase dimer disrupters induce DNA damage, halt cell growth and overcome drug resistance in colorectal cancer, Veterinary survey, Deliverables OHD
Institutions: Università degli Studi di Modena e Reggio Emilia (UNIMORE), Life Science, University of Modena and Reggio Emilia
https://orcid.org/0000-0002-0443-5402
Projects: de.NBI-SysBio, Kinetics on the move - Workshop 2016, Example use cases, SBEpo - Systems Biology of Erythropoietin, FAIRDOM & LiSyM & de.NBI Data Structuring Training, FAIRDOM, EnzymeML, GMDS Project Group "FAIRe Dateninfrastrukturen für die Biomedizinische Informatik", FAIRDOM Community Workers, MIX-UP, COVID-19 Disease Map, ERNEST Mapping Group Pilot Study, NMTrypI - New Medicines for Trypanosomatidic Infections, Standardization of enzyme-catalyzed reaction measurement, Standardization of enzyme-catalyzed reaction modelling, ModeleXchange initiative, CoVIDD - Coronavirus interactions in drug discovery - optimization and implementation, Mass spectrometry proteomics for biomarker discovery, Thymidylate synthase dimer dissociation, WG1 - Compound libraries coordination and integration of compound design, WG2 - Integration of early phase studies and low environmental impact actions, WG3 - Coordination of in vitro-to-in vivo translation of OneHealth leads and candidates, WG4 - Integration of R&D process-environmental studies and translation in informed whitepaper, WG5 - Promote dissemination, WG6 - Promote the transfer of knowledge, SABIO-VIS, SDBV/HITS, BioTarget Database, Compound Data, Veterinary survey, Deliverables OHD
Institutions: Heidelberg Institute for Theoretical Studies
https://orcid.org/0000-0002-9077-5664
The recent COVID19 pandemic infection has undisclosed long-standing issues in the translation of drugs from animals to humans or vice-versa. Nearly 75% of emerging human infections worldwide originated from animals; existing drugs for human and animal (H&A) vector-borne diseases (VBD) are scarce, with limited efficacy, toxicity, and finite resources. Emerging environmental problems in pharmaceutical use/manufacturing increase attention in the field. The two drug pipelines are developed ...
Projects: WG1 - Compound libraries coordination and integration of compound design, WG2 - Integration of early phase studies and low environmental impact actions, WG3 - Coordination of in vitro-to-in vivo translation of OneHealth leads and candidates, WG4 - Integration of R&D process-environmental studies and translation in informed whitepaper, WG5 - Promote dissemination, WG6 - Promote the transfer of knowledge, BioTarget Database, Compound Data, Veterinary survey, Deliverables OHD
Web page: https://onehealthdrugs.com/
Public web page: Not specified
